Alvotech (ALVO) Change in Taxes (2021 - 2026)
Alvotech (ALVO) posted Change in Taxes of -$278000.0 for Q1 2026, up 13.66% on a QoQ basis from -$322000.0 in Q3 2025, and down 826.67% year-over-year from $38256.9 in Q1 2025.
Alvotech (ALVO) Change in Taxes (2021 - 2026) Analysis & Trends
Alvotech's Change in Taxes history runs 6 years deep, the most recent figure standing at -$278000.0 for Q1 2026.
- Quarterly Change in Taxes fell 826.67% year-over-year to -$278000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$849000.0 (up 65.38% YoY) and the FY2023 annual result came in at -$1.4 million, down 62.35% from the prior year.
- Change in Taxes was -$278000.0 for Q1 2026 at Alvotech, up from -$322000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at -$30000.0 in Q1 2025 and bottomed at -$2.0 million in Q4 2024.
- A 5-year average of -$467500.0 and a median of -$209000.0 in 2024 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2025 — Change in Taxes surged 83.87% — and 2026, when it plunged 826.67%.
- Alvotech's Change in Taxes stood at -$834000.0 in 2022, then plunged by 62.35% to -$1.4 million in 2023, then sank by 50.44% to -$2.0 million in 2024, then soared by 84.19% to -$322000.0 in 2025, then increased by 13.66% to -$278000.0 in 2026.
- Business Quant data shows ALVO's Change in Taxes at -$278000.0 in Q1 2026, -$322000.0 in Q3 2025, and -$219000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 73.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -411.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -463.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 119.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | -278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -278,000.00 |
| Mar 31, 2026 | -278,000.00 |
| Sep 30, 2025 | -322,000.00 |
| Sep 30, 2025 | -322,000.00 |
| Jun 30, 2025 | -219,000.00 |
| Jun 30, 2025 | -219,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Dec 31, 2024 | -2.04 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Sep 30, 2024 | -199,000.00 |
| Sep 30, 2024 | -199,000.00 |
| Jun 30, 2024 | -186,000.00 |
| Jun 30, 2024 | -186,000.00 |
| Mar 31, 2024 | -186,000.00 |
| Mar 31, 2024 | -186,000.00 |
| Dec 31, 2023 | -1.35 Mn |
| Dec 31, 2023 | -1.35 Mn |
| Jun 30, 2023 | -536,000.00 |
| Jun 30, 2023 | -536,000.00 |